Literature DB >> 21680524

The cytoplasmic domain of Marburg virus GP modulates early steps of viral infection.

Eva Mittler1, Larissa Kolesnikova, Bettina Hartlieb, Robert Davey, Stephan Becker.   

Abstract

Marburg virus infection is mediated by the only viral surface protein, GP, a trimeric type I transmembrane protein. While its ectodomain mediates receptor binding and fusion of viral and cellular membranes and its transmembrane domain is essential for the recruitment of GP into budding particles by the matrix protein VP40, the role of the short cytoplasmic domain has remained enigmatic. Here we show that a missing cytoplasmic domain did not impair trimerization, intracellular transport, or incorporation of GP into infectious Marburg virus-like particles (iVLPs) but altered the glycosylation pattern as well as the recognition of GP by neutralizing antibodies. These results suggest that subtle conformational changes took place in the ectodomain. To investigate the function of the cytoplasmic domain during viral entry, a novel entry assay was established to monitor the uptake of filamentous VLPs by measuring the occurrence of luciferase-labeled viral nucleocapsids in the cytosol of target cells. This quantitative assay showed that the entry process of VLPs incorporating GP missing its cytoplasmic domain (GPΔCD) was impaired. Supporting these results, iVLPs incorporating a mutant GP missing its cytoplasmic domain were significantly less infectious than iVLPs containing wild-type GP. Taken together, the data indicate that the absence of the short cytoplasmic domain of Marburg virus GP may induce conformational changes in the ectodomain which impact the filoviral entry process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680524      PMCID: PMC3147980          DOI: 10.1128/JVI.00453-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Proteolytic processing of Marburg virus glycoprotein.

Authors:  V E Volchkov; V A Volchkova; U Ströher; S Becker; O Dolnik; M Cieplik; W Garten; H D Klenk; H Feldmann
Journal:  Virology       Date:  2000-03-01       Impact factor: 3.616

2.  Functional importance of the coiled-coil of the Ebola virus glycoprotein.

Authors:  S Watanabe; A Takada; T Watanabe; H Ito; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.

Authors:  Terri G Edwards; Stéphanie Wyss; Jacqueline D Reeves; Susan Zolla-Pazner; James A Hoxie; Robert W Doms; Frédéric Baribaud
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins.

Authors:  Olivier Reynard; Malgorzata Borowiak; Valentina A Volchkova; Sebastien Delpeut; Mathieu Mateo; Viktor E Volchkov
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

5.  Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies.

Authors:  H Ito; S Watanabe; A Takada; Y Kawaoka
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses.

Authors:  S Y Chan; C J Empig; F J Welte; R F Speck; A Schmaljohn; J F Kreisberg; M A Goldsmith
Journal:  Cell       Date:  2001-07-13       Impact factor: 41.582

7.  Vesicular release of ebola virus matrix protein VP40.

Authors:  J Timmins; S Scianimanico; G Schoehn; W Weissenhorn
Journal:  Virology       Date:  2001-04-25       Impact factor: 3.616

8.  Deletion of the cytoplasmic tail of the fusion protein of the paramyxovirus simian virus 5 affects fusion pore enlargement.

Authors:  R E Dutch; R A Lamb
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

9.  Acylation of the Marburg virus glycoprotein.

Authors:  C Funke; S Becker; H Dartsch; H D Klenk; E Mühlberger
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

10.  Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.

Authors:  Sina Bavari; Catharine M Bosio; Elizabeth Wiegand; Gordon Ruthel; Amy B Will; Thomas W Geisbert; Michael Hevey; Connie Schmaljohn; Alan Schmaljohn; M Javad Aman
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  8 in total

1.  A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model.

Authors:  Rohan Keshwara; Katie R Hagen; Tiago Abreu-Mota; Amy B Papaneri; David Liu; Christoph Wirblich; Reed F Johnson; Matthias J Schnell
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak.

Authors:  Erik Dietzel; Gordian Schudt; Verena Krähling; Mikhail Matrosovich; Stephan Becker
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

3.  Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies.

Authors:  Philipp A Ilinykh; Xiaoli Shen; Andrew I Flyak; Natalia Kuzmina; Thomas G Ksiazek; James E Crowe; Alexander Bukreyev
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

4.  Generation of therapeutic antisera for emerging viral infections.

Authors:  Rebecca Schmidt; Lea C Beltzig; Bevan Sawatsky; Olga Dolnik; Erik Dietzel; Verena Krähling; Asisa Volz; Gerd Sutter; Stephan Becker; Veronika von Messling
Journal:  NPJ Vaccines       Date:  2018-10-05       Impact factor: 7.344

Review 5.  Forty-five years of Marburg virus research.

Authors:  Kristina Brauburger; Adam J Hume; Elke Mühlberger; Judith Olejnik
Journal:  Viruses       Date:  2012-10-01       Impact factor: 5.048

6.  Analysis of determinants in filovirus glycoproteins required for tetherin antagonism.

Authors:  Kerstin Gnirß; Marie Fiedler; Annika Krämer-Kühl; Sebastian Bolduan; Eva Mittler; Stephan Becker; Michael Schindler; Stefan Pöhlmann
Journal:  Viruses       Date:  2014-04-09       Impact factor: 5.048

Review 7.  Marburg Virus Reverse Genetics Systems.

Authors:  Kristina Maria Schmidt; Elke Mühlberger
Journal:  Viruses       Date:  2016-06-22       Impact factor: 5.048

8.  Marburg virus regulates the IRE1/XBP1-dependent unfolded protein response to ensure efficient viral replication.

Authors:  Cornelius Rohde; Stephan Becker; Verena Krähling
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.